Clicky

Eckert & Ziegler Strahlen- und Medizintechnik AG(EUZ)

Description: Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.


Keywords: Natural Sciences Imaging Medical Imaging Radiation Prostate Cancer Medicinal Chemistry Radiation Therapy Laboratory Equipment Radiobiology Radiopharmaceuticals Treatment Of Prostate Cancer Medicinal Radiochemistry Iodine Measurement Technology Medical Imaging Systems Uveal Melanoma

Home Page: www.ezag.com

Robert-Rössle-Strasse 10
Berlin, 13125
Germany
Phone: 49 30 94 10 84 0


Officers

Name Title
Dr. Andreas Eckert Ph.D. Chairman of Exec. Board & CEO
Dr. Harald Hasselmann Head of Radiation Therapy Segment & Member of the Exec. Board - Medical Segment
Dr. Lutz Helmke Member of Exec. Board - Medical Segment
Dr. Gunnar Mann Head of Intragroup Services
Mr. Franklin B. Yeager Pres of Eckert & Ziegler Isotope Products Inc.
Mr. Joseph Hathcock VP of Eckert & Ziegler Isotope Products Inc
Ivan Simmer Managing Director of Eckert & Ziegler Cesio s.r.o.
Ms. Claudia Goulart MD - Eckert & Ziegler Brasil Participacoes, Comericial & Logistica Ltda.

Exchange: XETRA

Country: DE

Currency: Euro (€)

Forward PE: 0
Trailing PE: 37.6642
Price-to-Book MRQ: 5.2213
Price-to-Sales TTM: 4.6038
IPO Date:
Fiscal Year End: December
Full Time Employees: 945
Back to stocks